Navire Pharma, Inc.

Otsuka Holdings Co., Ltd. group companies Taiho Pharmaceutical Co. Ltd. and Astex Pharmaceuticals Ltd. have exclusively licensed to Merck & Co., Inc. global rights to their joint small molecule

Three venture capital funds announced during the last two weeks of October have $989m to invest in life science companies, which should help keep the biopharmaceutical VC financing boom going beyond 2

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. LianBio Launch Includes Deals With MyoK

Advanced therapies, pricing and reimbursement challenges, oncology breakthroughs and digital technologies are among the key topics for 2019 identified by biopharma industry players and watchers. Scri